ADAM ZAMORA: Open Payments
NPI 1548032006 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$382 in 18 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $37 · 2025 $382
Food & beverage: $382
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Vertical Pharmaceuticals, LLC | 2 | $36 |
| Boston Scientific Corporation | 1 | $32 |
| Lundbeck LLC | 1 | $31 |
| Biogen, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Alkermes, Inc. | 1 | $20 |
Products named: Azstarys, CAPLYTA, Relexxii, General - Pain Management, REXULTI, ZURZUVAE, UZEDY, ABILIFY MAINTENA.
Industry payments across AZ — which companies pay providers there.
